No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ENVB Enveric Biosciences
- 0.3250
- -0.0034-1.04%
Close Dec 20 16:00 ET
- 0.3294
- +0.0044+1.35%
Post 20:01 ET
3.23MMarket Cap-0.13P/E (TTM)
0.3366High0.3130Low202.11KVolume0.3143Open0.3284Pre Close65.65KTurnover2.16%Turnover RatioLossP/E (Static)9.94MShares2.920052wk High0.82P/B3.05MFloat Cap0.303652wk Low--Dividend TTM9.38MShs Float67500.0000Historical High--Div YieldTTM7.19%Amplitude0.3036Historical Low0.3240Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Enveric Biosciences Announces New U.S. Patents Supporting Evm301 Series and Evm201 Series Compounds
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | Enveric Biosciences : Plans to Submit Eb-003 Ind Application to FDA in H2 of 2025
Express News | Enveric Biosciences Preclinical Pharmacokinetic Studies of Eb-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-Like Behavior
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
Express News | Enveric Biosciences Inc: On Nov 20, Nasdaq Issued Delisting Notice on Failing to Meet Minimum Bid Price Requirement
Heat List
US
Overall
Symbol
Price
% Chg
No Data